The Value of In Vitro Diagnostics


Combining the science of advanced diagnostics with the physician’s art for a healthier future

The practice of medicine remains an art, but it’s science that drives the decisions doctors make. And the science never stops. Every day, medical research adds more information to the global knowledge base about the causes of disease, treatment options, and the ways patients respond.

That’s the challenge healthcare faces – how to take this boundless and complex amount of information and glean the essential insights to make the right decision at the right time. Fortunately, advanced diagnostics and aggregated healthcare data are helping turn that complexity into certainty, benefiting doctors, patients, and healthcare systems around the world.


Transforming in vitro diagnostics

The power of three: automation, digitalization, and integration are taking diagnostics beyond the lab and beyond what laboratory scientists would have believed possible just a few years ago. With the Integrated Core Lab (ICL), we are vastly expanding the efficiency, scope and quality of diagnostic capabilities.

Transforming in vitro diagnostics

With automation and digitalization, medical technologies and information systems can “talk” to each other in standardized language, helping laboratories perform more efficiently and successfully.

Integration puts all the pieces together – laboratory tests, imaging studies, medical histories and doctors’ reports – so that a complete picture of each patient is readily available and easily understood.


The value of Diagnostics lies in 'knowing'

Performed on blood, tissue or other patient samples, in vitro diagnostics are a critical source of objective information for improved disease management and patient care.

In modern healthcare, in vitro diagnostics go far beyond simply telling a doctor whether a patient has a certain disease or not. Today, they are an integral part of decision-making along the entire continuum of a patient’s health or disease, enabling physicians to make full use of IVDs along the healthcare value chain.

In vitro diagnostics (IVDs) have long been considered the “silent champion” of healthcare, influencing over 60 % of clinical decision-making, while accounting for only about 2% of total healthcare spending.

Diagnostics allows laboratories to be the reliable partners that healthcare professionals need. It empowers doctors to make the right decisions for their patients at the right time; it allows people to have improved control over their health and wellbeing; and it gives payers and policymakers the confidence that they are investing in the right solutions for patients and the future of healthcare.

Modern diagnostics reduces costs by diminishing subsequent health problems, reducing hospitalisation and avoiding unnecessary treatment. The future of sustainable healthcare depends on diagnostics.


The value of diagnostics lies in 'knowing'